7-124824014-TTA-T

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PVS1_Moderate

The NM_015450.3(POT1):​c.1851_1852delTA​(p.Asp617fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000628 in 1,609,030 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000067 ( 0 hom. )

Consequence

POT1
NM_015450.3 frameshift

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2U:3

Conservation

PhyloP100: 0.738
Variant links:
Genes affected
POT1 (HGNC:17284): (protection of telomeres 1) This gene is a member of the telombin family and encodes a nuclear protein involved in telomere maintenance. Specifically, this protein functions as a member of a multi-protein complex that binds to the TTAGGG repeats of telomeres, regulating telomere length and protecting chromosome ends from illegitimate recombination, catastrophic chromosome instability, and abnormal chromosome segregation. Increased transcriptional expression of this gene is associated with stomach carcinogenesis and its progression. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0283 CDS is truncated, and there are 0 pathogenic variants in the truncated region.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
POT1NM_015450.3 linkuse as main transcriptc.1851_1852delTA p.Asp617fs frameshift_variant 19/19 ENST00000357628.8 NP_056265.2 Q9NUX5-1A0A024R739

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
POT1ENST00000357628.8 linkuse as main transcriptc.1851_1852delTA p.Asp617fs frameshift_variant 19/192 NM_015450.3 ENSP00000350249.3 Q9NUX5-1

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152054
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000241
AC:
6
AN:
248612
Hom.:
0
AF XY:
0.0000223
AC XY:
3
AN XY:
134472
show subpopulations
Gnomad AFR exome
AF:
0.0000622
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000444
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000673
AC:
98
AN:
1456976
Hom.:
0
AF XY:
0.0000566
AC XY:
41
AN XY:
724944
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000848
Gnomad4 OTH exome
AF:
0.0000664
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152054
Hom.:
0
Cov.:
32
AF XY:
0.0000404
AC XY:
3
AN XY:
74268
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000868
Hom.:
0
Bravo
AF:
0.0000151
EpiCase
AF:
0.000109
EpiControl
AF:
0.0000595

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Tumor predisposition syndrome 3 Pathogenic:1Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingSt. Jude Molecular Pathology, St. Jude Children's Research HospitalAug 26, 2022The POT1 c.1851_1852del (p.Asp617GlufsTer9) change deletes two nucleotides and causes a frameshift and the creation of a premature stop codon. It is not expected to result in nonsense mediated decay and removes less than 10% of the protein. Functional studies have demonstrated the importance of the C-terminus of POT1 in protein-protein interactions, however studies are needed to determine the effect of this variant (PMID: 28393832; 28393830). This variant has been reported in an individual with a personal and family history of oligodendroglioma (PMID: 25482530) and in an individual with uveal melanoma (PMID: 32907878). This variant has a maximum subpopulation frequency of 0.0062% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance. -
Pathogenic, no assertion criteria providedliterature onlyOMIMDec 07, 2014- -
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 21, 2024This sequence change creates a premature translational stop signal (p.Asp617Glufs*9) in the POT1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 18 amino acid(s) of the POT1 protein. This variant is present in population databases (rs758673417, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with acute myeloid leukemia, colorectal cancer, head and neck squamous cell carcinoma, oligodendroglioma, and/or uveal and cutaneous melanoma (PMID: 25482530, 27329137, 29625052, 32191290, 32907878, 34193977). This variant is also known as c.1458_1459del. ClinVar contains an entry for this variant (Variation ID: 209095). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingAmbry GeneticsJan 26, 2024The c.1851_1852delTA variant, located in coding exon 15 of the POT1 gene, results from a deletion of two nucleotides at nucleotide positions 1851 to 1852, causing a translational frameshift with a predicted alternate stop codon (p.D617Efs*9). Frameshifts are typically deleterious in nature, however, this frameshift occurs at the 3' terminus of POT1, is not expected to trigger nonsense-mediated mRNA decay, and impacts only the last 18 amino acids of the protein. Another alteration, Q623H, located downstream of this frameshift was identified in a familial melanoma case, and has been shown to be important for binding to TPP1 and proper telomere maintenance (Shi J et al. Nat. Genet. 2014 May;46:482-6; Rice C et al. Nat. Commun. 2017 Apr;8:14928). Additionally, internal case control analysis showed a significant association of melanoma and sarcoma in probands heterozygous for c.1851_1852delTA compared to probands with a negative multigene testing panel result (Ambry internal data). Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGeneDxJun 09, 2023Frameshift variant predicted to result in protein truncation as the last 18 amino acids are replaced with 8 different amino acids, although loss-of-function variants have not been reported downstream of this position in the protein; This variant is associated with the following publications: (PMID: 27329137, 25710457, 25482530, 26847028, 32449991, 28393830, 34193977, 29625052, 32987645, 32907878) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs758673417; hg19: chr7-124464068; API